COMMUNIQUÉ RÉGLEMENTÉ
News
-
-
COMMUNIQUÉ RÉGLEMENTÉ
Disclosure of transactions in own shares from November 25 to November 29, 2024
-
-
-
-
-
COMMUNIQUÉ DE PRESSE
First Phosphate Corp. signe un accord de licence avec Prayon SA, leader mondial dans la technologie de l'acide phosphorique MGA
First Phosphate Corp. signe un accord de licence avec Prayon SA pour technologie d'acide phosphorique MGA. Accord inclut Ballestra pour services d'ingénierie. Partenariat avec Norfalco-Glencore pour approvisionnement en acide sulfurique -
-
COMMUNIQUÉ DE PRESSE
Jaguar Health Participating in December 3-5 Pet Connect Conference with Goal of Identifying Partner to Develop and Commercialize NP300 Second-Generation Antisecretory Prescription Drug Candidate for Treatment of General Diarrhea in Dogs
Jaguar Health Inc. announces extension of conditional approval by FDA for Canalevia®-CA1 drug for chemotherapy-induced diarrhea in dogs and seeks partners for NP300 prescription drug for general diarrhea in dogs at Pet Connect conference -
